Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherLetters to the Editor

Feasibility of Automated Partial-Volume Correction of SUVs in Current PET/CT Scanners: Can Manufacturers Provide Integrated, Ready-to-Use Software?

Sandip Basu and Abass Alavi
Journal of Nuclear Medicine June 2008, 49 (6) 1031-1032; DOI: https://doi.org/10.2967/jnumed.108.050401
Sandip Basu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abass Alavi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

TO THE EDITOR: The article by Soret et al. (1) in the June 2007 issue of The Journal of Nuclear Medicine on the implications of partial-volume effect (PVE) correction for PET in cancer provides a timely review of this important subject. It is quite clear that educating physicians—who are actively involved in the interpretation of PET images—is essential to correct for errors attributable to PVE. We congratulate the authors for their scholarly scientific communication and share our views on this topic in quantitative PET.

In recent years, a number of reports (1–3) have raised concerns about errors introduced by PVE in the quantitative assessment of tracer concentration with PET at intended sites. Although the initial reports dealt primarily with the measurement of metabolic values in the brain in different neurologic disorders (4–7), this effect has been increasingly recognized recently in malignant lesions (1–3,8–10). In addition to its importance in diagnosis, PVE correction has serious implications for treatment monitoring, an area in which a change in the standardized uptake value (SUV) is often used as an objective parameter to assess treatment response and in which lesions frequently become smaller after successful therapy. It is now proven that adoption of even a simple correction approach such as the recovery coefficient method can substantially reduce the error in uptake estimates of the lesions being examined.

The routine implementation of PVE correction in clinical practice is technically demanding and is an obstacle in most settings. By now, multiple clinical validation studies have addressed the importance of PVE correction and have suggested its use for accurate assessment of disease activity. However, successful implementation of this procedure would require a reproducible and relatively simple approach that can be performed on all patients.

Several PVE correction methods, including the popular recovery coefficient technique, require measuring the lesion dimensions in anatomic images such those produced by CT or MRI. The size estimate from current PET/CT scanners provides the opportunity to determine the PVE-corrected SUV readily. We believe the ever-increasing use of cross-sectional anatomic imaging with either CT or MRI along with the current-generation PET scanners can make this goal achievable through automated algorithms that provide the PVE-corrected SUV directly and easily. Until recently, the widespread use of PVE correction has been hampered primarily by the lack of integrated processing software with these hybrid scanners. With the use of fusion imaging in clinical practice becoming widespread, these limitations likely will not persist. We believe that manufacturers can assess the recovery coefficients for PVE correction for a particular scanner and integrate them into these scanners before they are installed at the site. The availability of a PVE-corrected SUV will be a strong step toward the routine use of this procedure at the clinical level, ultimately improving patient care. We speculate that eventually most scanners will have integrated automated PVE correction software. Both practitioners and the industry should be aware of the potential advantages of this evolution and take active steps toward bringing it about. Compared with the current schemes, integrated PVE software will strengthen the role and reliability of the SUV measurement as a quantitative measure.

In addition to the impact on routine patient care, such correction methods are expected to enhance the research applications of PET in the field of clinical oncology and other related disciplines. With PET/CT facilities being established in many centers across the world, it would be desirable for accurate clinical data to be generated not only from advanced and large university centers but also from small centers in communities with varying levels of expertise. The availability of integrated algorithms would likely improve reproducibility and reduce operator-dependent errors. Adoption of automated correction procedures that have been integrated with existing software will truly revolutionize the impact of this powerful modality worldwide. Every effort should be made toward achieving this goal.

Acknowledgments

This work was supported in part by the International Union against Cancer (UICC), Geneva, Switzerland, under the ACSBI fellowship.

Footnotes

  • COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.

References

  1. 1.↵
    Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932–945.
    OpenUrlAbstract/FREE Full Text
  2. 2.
    Basu S, Alavi A. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer? Eur J Nucl Med Mol Imaging. 2007;34:1527–1529.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Basu S, Zaidi H, Houseni M, et al. Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states. Semin Nucl Med. 2007;37:223–239.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Meltzer CC, Leal JP, Mayberg HS, Wagner HN Jr, Frost JJ. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr. 1990;14:561–570.
    OpenUrlPubMed
  5. 5.
    Chawluk JB, Alavi A, Dann R, et al. Positron emission tomography in aging and dementia: effect of cerebral atrophy. J Nucl Med. 1987;28:431–437.
    OpenUrlAbstract/FREE Full Text
  6. 6.
    Tanna NK, Kohn MI, Horwich DN, et al. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. Radiology. 1991;178:123–130.
    OpenUrlPubMed
  7. 7.↵
    Alavi A, Newberg AB, Souder E, Berlin JE. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J Nucl Med. 1993;34:1681–1687.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Hickeson M, Yun M, Matthies A, et al. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Eur J Nucl Med Mol Imaging. 2002;29:1639–1647.
    OpenUrlCrossRefPubMed
  9. 9.
    Alkhawaldeh K, Bural G, Kumar R, Alavi A. Impact of dual-time-point 18F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging. 2007 October 16 [Epub ahead of print].
  10. 10.↵
    Avril N, Rosé CA, Schelling M, et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol. 2000;18:3495–3502.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 49 (6)
Journal of Nuclear Medicine
Vol. 49, Issue 6
June 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Feasibility of Automated Partial-Volume Correction of SUVs in Current PET/CT Scanners: Can Manufacturers Provide Integrated, Ready-to-Use Software?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Feasibility of Automated Partial-Volume Correction of SUVs in Current PET/CT Scanners: Can Manufacturers Provide Integrated, Ready-to-Use Software?
Sandip Basu, Abass Alavi
Journal of Nuclear Medicine Jun 2008, 49 (6) 1031-1032; DOI: 10.2967/jnumed.108.050401

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Feasibility of Automated Partial-Volume Correction of SUVs in Current PET/CT Scanners: Can Manufacturers Provide Integrated, Ready-to-Use Software?
Sandip Basu, Abass Alavi
Journal of Nuclear Medicine Jun 2008, 49 (6) 1031-1032; DOI: 10.2967/jnumed.108.050401
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Redefining Nuclear Medicine: “Biodistribution” Should Be the Core Concept
  • Routine Dosimetry: Proceed with Caution
  • 176Lu Radiation in Long–Axial-Field-of-View PET Scanners: A Nonissue for Patient Safety
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire